Isotretinoin Belupo

Isotretinoin, the active ingredient in Isotretinoin Belupo, is a retinoid presented as oral capsules for oral use. It treats severe nodular acne and acne vulgaris in patients who require systemic therapy.

GNH USA supplies Isotretinoin Belupo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isotretinoin Belupo is a systemic retinoid indicated for severe forms of acne.

Severe nodular acne: markedly reduces inflammatory nodules and prevents new lesion formation. Acne vulgaris: decreases comedones and inflammatory papules in patients unresponsive to topical therapy. Recalcitrant acne: provides clinical improvement when conventional oral antibiotics have failed.

Isotretinoin may cause a range of adverse reactions.

Common Side Effects: - Dry skin and mucous membranes - Cheilitis (cracked lips) - Xerosis of eyes and nasal passages - Elevated liver enzymes - Increased serum triglycerides - Mild mood changes or irritability

Serious or Rare Side Effects: - Severe depression, suicidal ideation, or psychosis - Pancreatitis - Acute hepatitis or liver failure - Pseudotumor cerebri (intracranial hypertension) - Teratogenic birth defects - Hypercalcemia (rare)

Before initiating therapy, several safety considerations are required. - Pregnancy contraindication: avoid use in pregnant women due to teratogenicity. - Effective contraception: use two reliable methods throughout treatment and for one month after discontinuation. - Liver function monitoring: obtain baseline and periodic liver enzyme tests. - Lipid profile monitoring: assess triglycerides before and during therapy. - Avoid concurrent vitamin A supplements or other retinoids to prevent excess toxicity. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Isotretinoin can interact with several medicines, altering safety or efficacy.

Major Interactions (Avoid): - Tetracyclines: increased risk of intracranial hypertension. - Vitamin A supplements or other retinoids: additive teratogenic and toxicity risk. - St. John’s wort: may reduce isotretinoin plasma levels. - Systemic corticosteroids: heightened risk of pseudotumor cerebri. - Concurrent oral retinoids (e.g., acitretin): cumulative toxicity.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in contraceptive effectiveness. - Anticonvulsants (e.g., carbamazepine, phenytoin): enzyme induction may lower isotretinoin levels. - Antifungal agents (e.g., ketoconazole): may increase isotretinoin concentrations. - Antidepressants: monitor mood changes closely. - Lipid‑lowering agents: watch for additive effects on triglycerides.